⚠ Novel chemotype — no close known analogue (best Tanimoto < 0.3). Unexplored chemical space relative to ChEMBL.
Similar compounds — the chemically nearest patent molecules
Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.
| Compound | similarity | top predicted | shared targets | |
|---|---|---|---|---|
| SCHEMBL4951511 | 0.72 | — | — | |
| SCHEMBL9283513 | 0.72 | — | — | |
| SCHEMBL1228513 | 0.67 | — | — | |
| SCHEMBL5595733 | 0.60 | — | — | |
| SCHEMBL10398172 | 0.60 | — | — | |
| SCHEMBL11782718 | 0.60 | — | — | |
| SCHEMBL27589557 | 0.60 | — | — | |
| SCHEMBL3453387 | 0.59 | — | — | |
| SCHEMBL6236843 | 0.59 | — | — | |
| SCHEMBL11258005 | 0.59 | — | — |
Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.
Patent provenance — the patents this molecule appears in, and who filed them
Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.
| Patent | Title | Assignee | Published | Priority | Filing | Country | Status |
|---|---|---|---|---|---|---|---|
| EP-1267841-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING MIDODRINE AND/OR DESGLYMIDODRINE | Nycomed Austria GmbH (AT) | 2003-01-02 | — | — | EP | disclosed |
| WO-2001074334-A1 | CONTROLLED RELEASE PHARMACEUTICAL COMPOSITION CONTAINING MIDODRINE AND/OR DESGLYMIDODRINE | NYCOMED AUSTRIA GMBH (AT) | 2001-10-11 | — | — | WO | disclosed |